vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $24.0M, roughly 1.3× SIFCO INDUSTRIES INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -32.1%, a 39.6% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -4.5%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $25.0K). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
LFCR vs SIF — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $24.0M |
| Net Profit | $-10.0M | $1.8M |
| Gross Margin | 25.0% | 21.6% |
| Operating Margin | -9.9% | 10.7% |
| Net Margin | -32.1% | 7.5% |
| Revenue YoY | -4.5% | 14.8% |
| Net Profit YoY | -52.0% | 177.3% |
| EPS (diluted) | $-0.29 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $24.0M | ||
| Q3 25 | $31.1M | $22.8M | ||
| Q2 25 | — | $22.1M | ||
| Q1 25 | $35.2M | $19.0M | ||
| Q4 24 | $32.6M | $20.9M | ||
| Q3 24 | $24.7M | $21.7M | ||
| Q2 24 | — | $22.0M | ||
| Q1 24 | $35.7M | $20.5M |
| Q4 25 | — | $1.8M | ||
| Q3 25 | $-10.0M | $-429.0K | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | $-14.8M | $-1.4M | ||
| Q4 24 | $-6.6M | $-2.3M | ||
| Q3 24 | $-16.2M | $-443.0K | ||
| Q2 24 | — | $72.0K | ||
| Q1 24 | $15.6M | $-1.6M |
| Q4 25 | — | 21.6% | ||
| Q3 25 | 25.0% | 9.6% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | 28.0% | 8.3% | ||
| Q4 24 | 34.0% | 4.4% | ||
| Q3 24 | 21.8% | 10.7% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | 33.3% | 7.3% |
| Q4 25 | — | 10.7% | ||
| Q3 25 | -9.9% | -1.7% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | -25.7% | -4.1% | ||
| Q4 24 | -6.0% | -9.2% | ||
| Q3 24 | -46.9% | -1.5% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | -2.5% | -6.5% |
| Q4 25 | — | 7.5% | ||
| Q3 25 | -32.1% | -1.9% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | -42.0% | -7.3% | ||
| Q4 24 | -20.2% | -11.1% | ||
| Q3 24 | -65.7% | -2.0% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | 43.8% | -7.8% |
| Q4 25 | — | $0.29 | ||
| Q3 25 | $-0.29 | $-0.07 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | $-0.47 | $-0.23 | ||
| Q4 24 | $-0.25 | $-0.38 | ||
| Q3 24 | $-0.53 | $-0.07 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | $0.42 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $1.1M |
| Total DebtLower is stronger | $136.0M | $39.0K |
| Stockholders' EquityBook value | $-10.5M | $38.7M |
| Total Assets | $235.2M | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.1M | ||
| Q3 25 | $18.9M | $491.0K | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | $5.4M | $1.9M | ||
| Q4 24 | $9.5M | $3.1M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | $136.0M | $51.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | $97.1M | $4.1M |
| Q4 25 | — | $38.7M | ||
| Q3 25 | $-10.5M | $36.9M | ||
| Q2 25 | — | $35.8M | ||
| Q1 25 | $2.2M | $32.4M | ||
| Q4 24 | $15.4M | $33.7M | ||
| Q3 24 | $-3.9M | $30.4M | ||
| Q2 24 | — | $29.8M | ||
| Q1 24 | $17.7M | $29.7M |
| Q4 25 | — | $74.9M | ||
| Q3 25 | $235.2M | $73.4M | ||
| Q2 25 | — | $77.3M | ||
| Q1 25 | $237.7M | $78.8M | ||
| Q4 24 | $255.4M | $81.0M | ||
| Q3 24 | $246.8M | $104.6M | ||
| Q2 24 | — | $106.3M | ||
| Q1 24 | $246.2M | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | 5.49× | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $8.1M |
| Free Cash FlowOCF − Capex | $25.0K | $8.0M |
| FCF MarginFCF / Revenue | 0.1% | 33.3% |
| Capex IntensityCapex / Revenue | 5.6% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.1M | ||
| Q3 25 | $1.8M | $726.0K | ||
| Q2 25 | — | $371.0K | ||
| Q1 25 | $1.2M | $2.8M | ||
| Q4 24 | $-6.1M | $-3.8M | ||
| Q3 24 | $-613.0K | $857.0K | ||
| Q2 24 | — | $382.0K | ||
| Q1 24 | $-1.4M | $-3.2M |
| Q4 25 | — | $8.0M | ||
| Q3 25 | $25.0K | $566.0K | ||
| Q2 25 | — | $310.0K | ||
| Q1 25 | $-4.3M | $2.7M | ||
| Q4 24 | $-8.6M | $-3.9M | ||
| Q3 24 | $-4.0M | $580.0K | ||
| Q2 24 | — | $-175.0K | ||
| Q1 24 | $-7.8M | $-3.9M |
| Q4 25 | — | 33.3% | ||
| Q3 25 | 0.1% | 2.5% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | -12.1% | 14.1% | ||
| Q4 24 | -26.3% | -18.8% | ||
| Q3 24 | -16.3% | 2.7% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | -21.8% | -18.9% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 5.6% | 0.7% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 15.5% | 0.8% | ||
| Q4 24 | 7.5% | 0.5% | ||
| Q3 24 | 13.9% | 1.3% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | 17.8% | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
